We examinedour institution'sexperience with 22 cases of previously untreated buccal squamous cell carcinoma via a retrospective chart review. Eleven of these patients had been treated with a combination of surgical excision and postoperative radiation therapy, 8 patients with surgical excisionalone, and3patientswith radiation therapy alone. The overall 3-year locoregional recurrence rate was 32% (n =7). The 3-yearsurvivalrates were 82% aftersurgery plus radiation (9 of11 patients), 63% aftersurgery alone (5 of8), and 33% afterradiation alone (l of3). Three-year T-category-specificsurvival rates were 100%forcategory T1 tumors (3 of3 patients), 73% for T2 (8 of 11),50% for T3 (3 of 6), and 50%for T4 (l of2).Althoughthesmallsizeof ourstudyprecludedanystatistically significantconclusions, webelieve that locoregional control and survivalrates may begreater withsurgical excisionpluspostoperative radiation than with treatment with eithermodalityalone.
Introduction
Squamous cell carcinoma (SCC) of the buccal mucosa is a relatively uncommon cancer that is aggressive and associated with a high rate of recurrence. 1, 2 While buccal SCC is rare in the Western hemisphere, it is one of the most common forms of oral cancer in central and southeast Asia, primarily because the residents of those regions habitually chew tobacco and betel nuts. [3] [4] [5] For the most part, the treatment of buccal SCC has been based on (1) limited retrospective reviews of relatively small study populations and (2) clinical studies in which buccal SCC was grouped with other oral cavity carcinomas. In this report, we describe our institution's experience with buccal Scc.
Patients and methods
We searched the Department of Radiation Oncology database at the University of California, San Francisco (UCSF) and the UCSF tumor registry database and identified 60 patients who had been treated for biopsy-proven buccal SCC from January 1972 through December 2003 . Of this group, we excluded 38 patients who had either been previously treated elsewhere or whose lesions had initially arisen in another oral cavity site and involved the buccal mucosa only secondarily (cases ofbuccal SCC with involvement ofother oral cavity sites were included if it was clear from the clinical records that the tumor had originally arisen from the buccal mucosa).
We reviewed the charts of the remaining 22 patients-13 men and 9 women, aged 28 to 89 years (mean: 63)-for information on patterns of presentation, treatment, loco regional recurrence, and survival. Treatments included surgical resection alone, radiation therapy alone, and surgical resection plus postoperative radiation. No patient received chemotherapy as a primary treatment. Pathology reports were reviewed for invasion of adjacent nerve, muscle, bone, vasculature, and other structures.
Survival data were confirmed by examining the Social Security Death Index. The date of diagnosis was used as the starting point for calculating survival data. The Kaplan-Meier method was used to calculate outcomes data. Survival curves were compared by the log-rank test. Reported p values are for a two-sided hypothesis.
Approval for this study was granted by the UCSF Committee on Human Research.
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Results and analysis
Of the 22 pa tients in our study, 12 smoked tobacco; 2 of th ese 12 patients also chewed tob acco, an d 8 of th e 12 drank alcoho l. Only 1 of the 10 non -tobacco patients drank alcoho l. Diabetes an d hyp ertension were th e m ost common comorbidities, present in 5 patients each (l patient had b oth ).The most com mo n T category was T2 (n =11 [50% ]), and the m ost common N category was NO (n = 16 [73% ]); no pa tien t had a distant metastasis at presen tation (tab le 1). Follow-up ranged from 0.1 to 31 years (mean: 4).
Treatm ent. Of the 22 pa tients, 11 had been treated with bothsurgical excision and postoperative radi ation therapy, 8 with surgica l resection alone, and 3 with primary radia tion therapy. In all, 19 patient s underwent surge ry an d 14 received radiation. All tr eatments were intended to b e cura tive.
There were 3 patients with T1 tu mors, 11 with T2, 6 with T3, and 2 with T4 (table 2):
Tl tumor. All 3 patie nts wit h T l tu mors were trea ted with wide local excision . Two of th ese patie nts also underwent pos toperative radiation therapy.
T2 tumor. Of th e 11 pa tients wit h T2 lesion s, 9 underwent surgery-4 un derwent wide local excision, 3 composite resection (1with a superficialparoti dectomy), and 2 marginal man dibulectomy. Three of these 9 patient s also received postoperative radiatio n. Twopatients were treated with radiation alone.
T3 tumo r. Of the 6 patients with T3 lesion s, 5 were trea ted surgically-3 wit h wide local excision (1 in conj unction with a partial max illectomy) and 2 with composite resectio n. On ly 1 of these patie nts did not receive any postop erative radiation. One patient was treated with radiation alone.
T4 tumor. Both patien ts with T4 lesions underwent surgery an d postoperative rad iation therapy. One underwent wide local excision and the ot her un derwent a compos ite resection.
Radioth erapy.In 13 ofthe patients who received radiation alone or following surgery, th e cum ulative amo un t 
of radiation ranged from 50 to 71 Gy. The remaining patient develop ed severe m ucos itis and disconti nued treatment after 34 Gy; he died of disease 1 mo nth later.
No patient underwent preoperative rad iation therapy or concomitant chemotherapy or radiation the rapy. Surgery. Reconstruction following the 19 surgeries was achieve d with a primary closure in 4 cases, a local advancement flap in 4, a split-thickness skin graft in 3, a pectoralis major myocutan eou s flap in 3, a radial forearm free flap in 3, a trapezius flap in 1, and a scapula flap in 1 (tab le 2).
The surgical margins were negative in 20 of the 22 patients. The 2 patients with pos itive m argins had T3 lesion s.Both were sched uled for postoperative radiatio n therapy, but 1 declined further treatment and died of disease 3 months later. The ot her patient did undergo postoperative radiation therapy an d was alive witho ut disease at 5 years.
Three patients had close surg ical margins of resection, and 2 of them underwent postoperative radiatio n th erapy; 1 was alive without disease 1year later, and the other died 1 m onth after the comp letion of radiation treatment. The th ird patient, who had a T2NO lesion, declined pos toperative radiation th erapy initia lly. He subseq uen tly developed a recurrence of the primary 3 months later and underwent further surgery, whic h involved a radical resection, a supe rficial parotidectomy, a modified radical neck dissectio n, and latissimus dorsi flap reco nstruction . Th is time, he did agree to undergo pos toperative radiation th erapy. H is surgical margins at the primary site were negative, but his neck dissec - Neck treatment failed in 2 patients, both of whom were NO. One of these patients had undergone resection of a T1 lesion and postoperative radiation to the primary; he experienced a recurrence in the neck that was treated electively with 66 Gy of radiation therapy. The other patient had undergone resection of a T2 lesion with close margins and had initially declined postoperative radiation therapy (his case is described in the preceding paragraph) . Radiation doses to the neck ranged from 50 to 66 Gy.
Three of the 13 neck dissections were positive for metastatic lymph nodes. One of these occurred in the patient with T3 disease (T3N2b) and positive surgical margins who declined postoperative radiation therapy and died of disease 3 months later (described earlier). Another patient had undergone surgical treatment of the primary tumor and a neck dissection for a T2N1 lesion but declined postoperative radiation therapy; he was alive without disease at 2 months.The third patient also had a T2N1lesion. He received postoperative radiation therapy but developed a recurrence at the site of the primary tumor despite clear margins. He subsequently underwent a left hemimandibulotomy and maxillectomy. He lived for an additional 15 years.
The other 2 patients with clinically positive neck disease (N1) who underwent neck dissection had negative nodes on pathology.One receivedpostoperative radiation therapybut died 1month after the completion of therapy, and the other declined further treatment and was alive without disease at 1 month of available follow-up.
Recurrence.The overa1l3-yearlocoregional recurrence 584· www.entjournal.com rate was 27% (6 of22 patients) . The 3-year T-categoryspecific recurrence rates were 33% for categoryT1tumors (1 of 3 patients), 27% for T2 (3 of 11), 33% for T3 (2 of 6), and 0% for T4 (0 of 2). Five of the 610coregional recurrences occurred at the primary site; the other occurred in the neck. The 3-year locoregional recurrence rates according to the type of treatment were 18% for surgery plus radiation therapy (2 of 11 patients), 67% for primary radiation only (2 of 3), and 25% for surgery only (2 of 8). While there was clearly a trend toward a higher risk of recurrence among patients who did not undergo surgery, the difference was not statistically significant (p =0.0691).
There was a trend toward greater locoregional recurrence in patients who had perineural invasion, but the association did not reach the threshold for statistical significance; the loco regional recurrence rates in patients with and without perineural invasion were 67% (4 of 6 patients) and 19% (3 of 16), respectively. One patient who had evidence ofbone invasion on pathology did not experience a recurrence. There were no cases ofvascular invasion. All groups were too small for any meaningful statistical analysis.
Survival.The 3-yearT-category-specific survival rates were 100% for category T1 tumors (3 of 3 patients), 73% for T2 (8 of 11), 50% for T3 (3 of 6), and 50% for T4 (1 of2) ( figure 1) .
The 3-year survival rates according to the type of treatment were 82% for surgery plus radiation (9 of 11 patients), 33% for primary radiation only (1 of 3), and 63% for surgery only (5 of 8) (figure 2).
Patients who were initially categorized with N-positive disease were less likely to survive beyond 3 years (2 of 6 [33%]) than those initially categorized as N-negative (12 of 16 [75%].
Of the 3 patients who had been treated with primary radiation alone, on ly 1was alive at 31 years offollow-up. This patient did develop a recurrence at the primary site 11 years after initial treatment, and he underwent surgical salvage with negative margins and a negative neck dissection. At the final follow-up, he was without disease. Another patient underwent surgical salvage 2 months after completing radiation therapy, but his cancer recurred 5 months later and proved to be fatal. The third patient had persistent disease after radiation and underwent palliation with chemotherapy.
Discussion
Treatment of buccal see has been difficult to study prospectively and to standardize because (1) this tumor is uncommon in the Western hemisphere and (2) it is aggressive, more so than other tumors of the oral cavity.1,2
In the present study, the percentage of patients who smoked or chewed tobacco was 55%, which is lower than the 67 to 100% rates reported in other stu dies of buccal carcinoma.P " The percentage of women in our study (41%) is withi n the range seen in other studies (35 to 67%) . 1, 2, 5, [7] [8] [9] Interpretation of our data is limi ted by the fact that .our population was made up of a. small number of patients who were all treated at one insti tu tion. Nevertheless, our experience suggests that treatment with a combination of surgery and postoperative radiation yields higher 3-year survival rates than treatment with either modality alone (82 vs. 63 and 33%, respective ly). However, because the number of pat ients in our study was so small, none of the differences among gro ups achieved statisticalsign ificance. The only difference that approached statistical significance (p = 0.0691) was the lower rate of locoregional recurrence at 3 years seen in patients who had undergon e surgery compared with those who had not.
The results of other studies in the literatur e suggest that surgery, with or without radiation therapy, confers better loco regional control and survival.6,7,10-13Chhetri et al descr ibed 27 cases of buccal carcinoma and reported 3-year survival rates of 68% after combined therapy, compared with 38% after surgery alone." In a study of 31 pat ients, Strome et al reported a 5-year locoregional recurrence rate of 100% for patients with stage I and II tumors who were treated with wide local excision alone. ' Sieczka et al studied 27 patients who were treated with surgery alone and found a locoregional recurrence rate of56%.10 Nair et alstudie d 234 patients who were treated with radiation therapy alone and found an overa1l3-year survival rate ofonly 42%; the 3-year locoregional recurrence ratewas47%.11 Fangetal treated , -----------------------------, 57 patients with combined surgery and radiation therapy and reported a 3-year survival rate of55%, a 3-year disease-specific surviva l rate of 62%, and a 3-year actuarial locoregional control rate of 64%.12 On the ot her hand,in a study of 40 patients treated either with preoperative radiation followed by surgery, wit h primary surgery alone, or with radiation alone, Pop et al found a similar incidence of Figure 2 . Graph showssurvivalby type of treatment. The log-rank p valueis 0.8958. N-positive neck disease did worse than those who were N-negative in terms of 3-year survival-33 and 75%, respectively.This would suggestthat aggressivetreatment of the neck is warranted. Still, in view of the small size of our sample, it is difficult to draw any strong conclusions regarding these prognostic factors.
In conclusion, buccal SCC is an aggressive cancer that is associated with a high rate oflocoregional recurrence.P For patients with tumors of all T categories ,we believe that loco regional control and survival may be improved with a combination of surgica l resection and postoperative radiation therapy. Because patients with neck disease tend to do poorly, aggressive treatment of the neck is recommended.
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22%. It is possible that the degree of mucosal disease and the presence of nasal polyps in our unse lected group of patients with chronic rhinosinusitis obscured the presence of some pneumatized superior turbinates on conventional high-resolution CT. Also, it is difficult to assess whether all the pneumatized cells that Van Alyea observed under direct vision would be detectable by CT.
In addressing the superior turbinate surgically, one must be cognizant not on ly of its anatomic relationships , but also its role in the distribution of olfactory muco sa. The structure should be manipulated gently because an aggressive debridement might damage the olfactory mucosa or disrupt the cribriform plate and cause a cerebrospinal fluid leak.
Further studies of superior turbinate pneumatization that corre late symptoms, treatment, and outcomes with radiographic findings may help elucidate the impact that such pneumatization may have on the etiology of sinus and nasal symptoms. Also, a greater awareness of the superior turbinate by oto laryngo logists and radiologists during the treatment of sinus and nasal disease may help to further define the significance of this superior turbinate pneumatization. Finally, otolaryngologists should have a good understanding of the anatomic relationships of the superior turbinate when considering it in the pathophysiology of a sino nasal disease process and, of course, when addressing it surgically.
